BACKGROUND: Small for gestational age children (SGA) is born on term with BW and or BL of -2.0 standard deviation score (SDS). SGA children have an increased risk of being short, developing DM, and cardiovascular and cerebrovascular disease. Often defects of IGF1R are the cause of SGA. Most frequently affected part of the IGF1R gene is the exon 2.
Introduction
SGA children comprise 3% of all births. Those are the children with birth weight (BW) and/or birth length (BL) less than 2.0 standard deviation score (SDS). Only 10% of children do not attain normal height until the age of four or five years. In fact, that 10 % have a higher risk to remain short, as well as increased prone to diabetes mellitus, cerebrovascular and cardiovascular diseases in adulthood [1] .
The aetiology of SGA is heterogeneous. Genetic factors are a culprit in some of them. Defects in IGF1R gene are reported as a cause of SGA [2] [3] [4] . The most affected part of the IGF1R gene is its exon 2.
Insulin-like growth factor 1 receptor (IGF1R) is a heterotetrameric (α2β2) transmembrane glycoprotein with intrinsic kinase moiety. It contains 2 alfa and two beta subunits synthetized by one mRNA precursor (α2β2). IGF-1R and IR (insulin receptor) are parts of the same family together with IGF-2R and their ligands IGF-1 and IGF-2 and at least 6 IGFbinding proteins, so-called protein kinase superfamily or tyrosine protein kinase family and insulin receptor subfamily [5] [6] [7] [8] . GF1R and IR receptors are found in skeletal muscles, heart, kidneys, fat tissue, liver, spleen, fibroblasts and placenta.
We investigated the exon 2 of the IGF-1R gene, as this gene part is the often affected by nucleotide alterations. 100 SGA children were analysed.
Patients and Methods
The cohort of 100 (M:F = 40:60) children born in term (≥ 37 GW), but small for gestational age is composed of two groups: a group of 64 (M:F = 31:33) SGA born children who did not achieve catch-up growth after the 2nd year and remained short and a group of 36 (M:F = 13:23) SGA born children (older than 4 years) with normal growth spurts for their age and sex.
Anthropometric data and IGF-1 concentrations were evaluated. IGF1-BP3 was not available. Clinical birth data include children's birth weight (BW) in kilograms, BW standard deviation score (SDS), birth length (BL) in centimetres, BL SDS and gestation week (GW). Also, the height SDS, weight SDS, occipitofrontal circumference SDS, body mass index (BMI), BMI z-score and target height (TH) SDS were also analysed.
The serum concentrations of Insulin-like growth factor 1 (IGF1) were determined by chemiluminescence immune assay method on IMMULITE 2000 Siemens, Immunoassay System apparatus.
The molecular analysis of IGF1R gene was performed on ("Biometra"-T3 Thermocycler PCR apparatus) in Laboratory for Molecular medicine in University Children's Hospital Skopje. Start DNA material was isolated from leukocytes with high concentrated 5 M NaCl solution. This genomic DNA material of particular exon 2 was amplified using the polymerase chain reaction (PCR) to perform the restriction-site analysis. We used following primers: 5'TCGACATCCGCAACGACTATC3' as the forward primer and the 5'CGAAGATGACCAGGGCGTAG3' as reverse primer. PCR products were digested with Dde I (Sigma Aldrich), and the resulting fragments were characterized by 1% agarose gel horizontal electrophoresis and staining with ethidium bromide. PCR products of coding IGF1R exon 2 were screened by direct sequencing of conspicuous fragments in Molecular Laboratory of Faculty of Pharmacy.
The Kolmogorov-Smirnov test (KS test) is used to check whether the values have a normal (Gaussian) distribution. A confidence interval (CI) is calculated for the mean of each of the quantities. For the comparison of 2 groups, Fisher's test is used to check the equivalence of variances. The result of this test is relevant for applying the test for equivalence of means. If the 2 samples have a size greater than 30, a z-test is used, otherwise a t-test. All tests are with a 99% significance or α = 0.01.
Results
The mean birth weight (BW) and BW standard deviation score (BW SDS), birth length (BL) and BL SDS were: in 64 short children BW 2284.37 gr ± 433 SDS and BW SDS -2.71 ± 1.05 SDS, BL 47.06 ± 2.09 SDS and BL SDS -1.33 ± 1.03 SDS and in 36 children with normal height BW 2502.5 gr ± 317.8 SDS and BW SDS -2.15 ± SDS and BL 46.63 cm ± 2.12 SDS and BL SDS -1.61 ± 1.12 SDS (Table 1) . Short children had measured height SDS (H SDS) (-3.25 ± 0.90 SDS), weight SDS (W SDS) (-2.72 ± 1.39 SDS), BMI z-score (0.88 ± 1.78 SDS) and occipitofrontal circumference SDS (OFC SDS) (-0.70 ± 1.01 SDS) at the time of entrance the study. Growth parameters of children with caught up growth were: H SDS (0.20 ± 1.1 SDS), W SDS (0.29 ± 1.53 SDS), BMI z-score (0.01 ± 1.68 SDS) and OFC SDS (0.06 ± 0.56 SDS) ( Table 2 ). None of our SGA born children had dysmorphic features.
Only in one boy with short stature (-2.63 SDS) had low normal IGF1 serum concentration (52.3 https://www.id-press.eu/mjms/index ng/ml, N = 50-286) and IGF1 SDS (-1.57 SDS) for his age and sex. The PCR restriction-site analysis in all SGA born children did not show any genetic alteration in exon 2 of IGF1R gene. The screened PCR products coding IGF1R exon 2 by direct sequencing of conspicuous fragments were uneventful. Homozygous defects in the IGF1 gene have been found in patients with major developmental impairments and severe intrauterine and postnatal growth retardation. On the other hand, mutations in IGF1R gene that have been predominantly heterozygous are 3 found in patients with mild phenotype and clinically heterogeneous presentation [20] .
Discussion
Since 2003y Abuzzahab et al., [10] described 2 point mutations in exon 2 of IGF1R gene: the first was compound heterozygosity with the exchange of arginine by glutamine at amino acid 108 (p. R108Q) and exchange for lysine by asparagine in the amino acid 115 (p. K115N) in SGA born girl with delayed motor development, psychiatric problems and growth retardation. The authors also described another heterozygous mutation in the éxon 2 (p. R89X) in an IUGR born boy with microcephaly, short stature and delayed motor and speech development.
Kawashima et al., [11] in 2005 described missense mutation in heterozygosity at 11 éxon the IGF1R (p. R739Q) in a SGA born patient with significant mental retardation and postnatal growth. In SGA born 35 y old patient with microcephaly and elevated IGF1 values, Walenkamp et al., [12] 2006y found a mutation in the éxon 16 (p. E1050K). Inagaki et al., [13] 2007y found heterozygous point mutation resulting in R481Q in a girl with short stature and elevated IGF1 values. Kruis et al., 2010y [14] in 7 members of the same family with low BW, microcephaly and normal mental development, reported similar mutation which resulted in G1125A protein.
Wallborn et al., [15] We investigated 100 SGA born children, 64 children were with short stature -H SDS (-3.25 ± 0.90 SDS) and 36 children with normal height -H SDS (0.20 ± 1.1 SDS). They were born with low BW SDS (-2.71 ± 1.05 SDS) vs (-2.15 ± 0.56 SDS) and/or BL SDS (-1.33 ± 1.03 SDS) vs (-1.61 ± 1.12 SDS). No alterations in exon 2 of the IGF1R gene were found.
The IGF1 serum concentration only in one patient of our cohort was in the lower normal range for his age and sex at the time of diagnosis. The defects of IGF1R usually result in elevated IGF1 serum concentrations [2] [12] [13] [15].
In conclusion, within a cohort of 100 SGA born children without microcephaly or dysmorphic features we did not find alterations in the exon 2 of the IGF1R gene. Exon 2 of the IGF1R gene might not be a hotspot for alterations. Investigating most or the whole of the IGF1R gene together with other genes implicated in SGA might yield an answer on the SGA cause of a particular child.
